OLR1 and glioblastoma: A study revealed that the Polymorphonuclear (PMN) MDSC that expressed lectin-type oxidized LDL receptor 1 (LOX-1) inhibited T cell proliferation and enhanced immune suppression, which may play a key role in driving GBM progression (31).